INVESTED: High-Dose vs Standard-Dose Influenza Vaccine in High-Risk Cardiovascular Disease Patients

November 13-17, 2020; Virtual Conference
High-dose trivalent influenza vaccine was comparable to standard-dose quadrivalent vaccine regarding deaths or cardiopulmonary hospitalizations.
Format: Microsoft PowerPoint (.ppt)
File Size: 217 KB
Released: November 20, 2020

Acknowledgements

Provided by Clinical Care Options

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
Merck

Related Content

Expert video from Clinical Care Options (CCO) on optimal prevention and management of CV morbidities in settings of heart failure, diabetes, and CKD

Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC Javed Butler, MD, MPH, MBA Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: December 15, 2020 Expired: December 14, 2021

CCO slides from Deepak Bhatt, Javed Butler: Latest on SGLT2 inhibitors in HF, emerging therapies in HFrEF, timing of ARNI initiation in decompensated HF, and more.

Released: December 9, 2020

Expert commentary on key highlights in heart failure from AHA 2020, provided by Clinical Care Options

Javed Butler, MD, MPH, MBA Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Released: December 9, 2020 Expired: December 8, 2021

Vericiguat VICTORIA subgroup analysis from AHA, as reported by CCO

Released: November 18, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue